[1]
Dąbrowska, A.M. et al. 2013. Could osteoprotegerin serve as a marker of metabolic syndrome?. Current Issues in Pharmacy and Medical Sciences. 26, 3 (Sep. 2013), 309–312. DOI:https://doi.org/10.12923/j.2084-980X/26.3/a.15.